KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
In response to the health emergency, international agencies, including the World Health Organization, are supporting local medical teams with logistics, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use framework while medical researchers gather observational data on its effectiveness against the viral strain circulating in the region. DR Congo launches Ebola vaccination campaign as health workers intensify ring-vaccination strategies around identified infection clusters to isolate viral transmission chains.
Health Ministry Assigns Priority to Ervebo Doses for Medical Staff in Kisangani
Operational challenges hinder logistics due to the complex regional infrastructure, ongoing security issues, and high population mobility across border districts. Cold-chain supply networks have been established in Kisangani to maintain the ultra-low temperatures required for vaccine storage prior to transport to outlying health zones. DR Congo launches Ebola vaccination campaign while civil defense and community health workers conduct educational outreach to improve disease surveillance and reporting.
Collaborations between epidemiologists from the Africa Centres for Disease Control and Prevention and local response units are ongoing to monitor adverse events and assess immune responses among vaccinated populations. Early detection and isolation protocols, combined with supportive care, are emphasized as vital for enhancing patient survival prospects. Additional vaccine shipments are planned to expand regional distribution across secondary health districts.
Strict Infection Control Measures Enforced by Health Authorities in Ebola Treatment Facilities
Contact-tracing operations continue to expand across urban and rural areas within the eastern territories. Personal protective equipment, diagnostic reagents, and therapeutic supplies are being distributed to municipal health centers to strengthen their readiness. The government affirmed that comprehensive public health measures will stay in place until data shows a sustained decline in viral transmission across all affected provinces.
Local communities are urged by authorities to fully cooperate with mobile vaccination teams and follow established sanitary protocols. It is expected that increased immunization coverage among high-risk populations will stabilize infection rates over the coming weeks. Surveillance networks will keep heightened monitoring across transportation hubs and border crossings to prevent further regional spread.